Bank vs. CMBS vs. Life Company: How to Choose the Right Permanent Lender for Your Deal
In 2026, a well-qualified commercial real estate borrower with a stabilized asset can get a quote from three completely different lender categories: a bank, a CMBS conduit, or a life insurance company. All three may offer similar business terms, but the largest difference between them is not the rate. It is everything that comes after closing.
Choosing the wrong source costs borrowers in ways that do not show up until they need flexibility, want to sell early, or find themselves dealing with a servicing process that was not designed for human conversation. Here is how to think through the decision.
The Bank Loan: Flexibility and the Relationship
Bank balance-sheet loans are originated and held by the bank directly, which means the lender retains full control of the borrower relationship throughout the loan term. Current bank CRE rates in 2026 run approximately 6.00% to 8% depending on property type, borrower strength, and market, with typical parameters of 65% to 75% LTV, 20 to 25-year amortization, and 5 to 10-year terms with balloon payments.
The defining feature of a bank loan is flexibility. If circumstances change mid-term, the bank can modify. If you want to sell early, there is no defeasance calculation. If you have a relationship with the bank, that relationship can produce preferred pricing and terms that are not available to a cold applicant. The trade-off is recourse. Most bank CRE loans require a personal guaranty, which means your broader balance sheet is exposed to the specific asset's performance.
Bank loans are the right answer when the borrower values flexibility above all else, has a strong existing banking relationship, anticipates the need to modify terms or exit before maturity, or is working on a deal size below what CMBS efficiently handles (typically under $5M to $10M).
The CMBS Loan: Scale, Leverage, and the Loss of Control
CMBS (Commercial Mortgage-Backed Securities) loans are originated by conduit lenders, then pooled with other commercial loans and securitized into bonds sold to investors. CMBS issuance hit $158 billion in 2025, the highest level since 2007. Current CMBS rates in 2026 run approximately 6.25% to 7.50% on a 10-year fixed with 30-year amortization for most property types, with LTVs up to 70%-75% for multifamily and industrial, tighter for office and hotel.
The defining advantages of CMBS are non-recourse financing and higher leverage. For large deals, CMBS provides access to loan amounts that bank concentration limits would not allow. For borrowers who want to protect their personal balance sheet, non-recourse with standard carve-outs is a meaningful benefit.
The trade-off is inflexibility. Once a CMBS loan is securitized, it is governed by a pooling and servicing agreement rather than by the relationship lender who originated it. Loan modifications are nearly impossible mid-term. Prepayment via defeasance or yield maintenance can be expensive, particularly when rates are below the original coupon. If a major tenant leaves, or if circumstances require an early sale or refinance, the CMBS structure creates friction that a bank loan would not.
CMBS is the right answer when the borrower has a stabilized property with strong NOI, a genuine intention to hold through the full loan term, no need for early prepayment optionality, and a deal size above $5M where CMBS economics work efficiently.
The Life Company Loan: Lowest Rate, Best Servicing, Highest Bar
Life insurance company loans are funded directly off the insurer's balance sheet and held to maturity. Like bank loans, the lender relationship stays intact throughout the term. Unlike bank loans, life company financing is typically non-recourse with the lowest rates available for stabilized, low-leverage, high-quality commercial real estate.
The rate lock at application is a differentiator found nowhere else in permanent CRE financing. Life companies will often lock the rate when the loan application is submitted, six months or more before closing. In an environment where the 10-year Treasury is elevated and the next major rate catalysts are upcoming Fed meetings and inflation data, that lock provides genuine protection.
The trade-off is selectivity. Life companies require stabilized assets with durable cash flow, clean operating histories, and experienced sponsorship. They typically cap LTV at 65% to 70%. Properties with rollover risk, lease-up uncertainty, or borrowers without an established track record will not typically qualify.
Life company financing is the right answer when the deal is stabilized, the borrower is experienced, leverage is conservative, and long-term fixed-rate certainty is more valuable than flexibility or maximum proceeds.
How to Make the Decision
Start with three questions. First, do you need flexibility during the loan term? If yes, bank. Second, do you have any chance of selling or refinancing early? If yes, bank or life company over CMBS. Third, is the deal below $5M to $10M? If yes, bank or life company. Everything else being equal, get quotes from all three and compare all aspects, not just the rate.
How SF Capital Can Help
SF Capital places commercial real estate debt across all three of these lender categories and across the full capital stack beyond them. We help borrowers understand which structure fits their specific situation before they go to market, and we get competitive quotes across sources so the decision is based on real numbers rather than assumptions. Contact the SF Capital team to start the conversation.
